Related Experiment Video
Updated: Jul 13, 2026
State of the Art Cranial Ultrasound Imaging in Neonates
Published on: February 2, 2015
Structures for clinical follow-up: newborn screening
R Rodney Howell1, Gilian Engelson
1Department of Pediatrics, Miller School of Medicine, University of Miami, P.O. Box o16820, Miami, FL 33101, USA. rhowell@miami.edu
Insights
Clinical follow-up for infants identified through newborn screening is crucial. Establishing a systematic, nationwide process ensures consistent, timely, and effective care for all infants, improving health outcomes.
Area of Science:
- Public Health
- Pediatrics
- Genetics
Background:
- Clinical follow-up is vital for managing newborn infants identified via newborn screening.
- Significant challenges exist in the U.S. newborn screening program, including inconsistent follow-up practices and protocols among states.
- There is a need for a systematic approach to newborn follow-up care and a national infrastructure for consistent treatment.
Purpose of the Study:
- To advocate for a systematic process for clinical follow-up of infants identified through newborn screening.
- To emphasize the need for a nationwide infrastructure to ensure consistent and effective treatment for all infants.
- To highlight the importance of structured follow-up for studying natural history, monitoring outcomes, validating screening, and advancing therapies.
Main Methods:
- This study is a review and synthesis of current challenges and recommendations for newborn screening follow-up.
- It analyzes variations in state practices and treatment protocols.
- It proposes the development of a structured, nationwide clinical follow-up system.
Main Results:
- Current newborn screening follow-up practices in the U.S. are inconsistent across states.
- There is a lack of standardized diagnostic and treatment protocols among healthcare providers.
- A structured, nationwide follow-up system is proposed as essential for optimal infant care.
Conclusions:
- A structured clinical follow-up system is necessary to ensure equitable and effective care for all infants identified through newborn screening.
- Such a system will facilitate research into disease natural history, outcomes, and the development of new interventions.
- Implementing a nationwide infrastructure is key to advancing the clinical management of screened conditions.
Abstract:
Clinical follow-up of children identified by newborn screening is critical in ensuring that the short-term and long-term needs of the newborn infant are managed. Within the United States, one of the biggest challenges in the newborn screening programme is clinical follow-up, and there still remains wide variation in practice patterns among states on how infants are followed up. In addition, there is lack of consistency in the treatment and diagnostic protocols used by health care providers. There is growing interest in the establishment of a systematic process for follow-up and for the development of a nationwide infrastructure that will ensure that all children will be provided consistent and effective treatment in a timely manner. Within this framework of optimal diagnosis and therapy, there must also be opportunities to study the natural history of these conditions, to monitor short- and long-term health outcomes, to assist with policy decision-making, to validate the effectiveness of screening, to define the clinical spectrum of the diseases, and to provide opportunities for the advancement of novel therapeutic interventions and screening/diagnostic technologies. It will only be through the development of a structured clinical follow-up system that we will be able to make certain these newborn infants are provided the most appropriate treatment for their disease variants and allow researchers to make more rapid advances in improving the clinical management of these conditions.